The Physician and the Invisible Patient

This flow traces the emotional and ethical bond between clinical observation and patients whose HCV disease is often silent.

increasingBearing stren­gth in each eventdecreasing

Silent Infection

Silent Infection Little to feel Many infected people have no knowledge of their infection and few symptoms. The absence of pain or jaundice creates distance between disease burden and personal awareness. Clinical responsibility Screening must bridge that distance. The physician acts before the patient has a narrative of illness, converting hidden risk into an opportunity for prevention.

Invisible Fibrosis

Invisible Fibrosis The body appears stable A dialysis patient may have advanced fibrosis while transaminases remain low. The patient’s apparent stability conflicts with the tissue’s accumulating damage. Trust through investigation Liver biopsy imposes risk and anxiety, but it gives the patient a clearer future. The relationship depends on explaining why an invasive test is necessary when the patient feels well.

Surveillance Bond

Surveillance Bond Repeated attention Annual viral testing, liver review, urine monitoring, and metabolic assessment keep the patient visible during years of waiting. Surveillance is a form of continuity in a disease defined by delay. Protection against disappearance The patient can deteriorate between major procedures. Regular follow-up preserves the possibility of timely treatment or a change in transplant strategy.

at first diagnosis

during transplant assessment

during long-term waiting-list follow-up